SCHEMBL6982097

SCHEMBL6982097

COc1cc(Nc2nccc(-c3cccc(OCCCN4C(=O)c5ccccc5C4=O)c3)n2)cc(OC)c1OC

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ZAP70 P43403 10/20 0.56
PRKCA P17252 4/20 0.56
PRKCD Q05655 4/20 0.56
PRKD3 O94806 3/20 0.56
PRKCG P05129 3/20 0.56
PRKCB P05771 3/20 0.56
LCK P06239 3/20 0.56
PRKCH P24723 3/20 0.56
PRKCI P41743 3/20 0.56
PRKCE Q02156 3/20 0.56
PRKCQ Q04759 3/20 0.56
PRKCZ Q05513 3/20 0.56
PRKD1 Q15139 3/20 0.56
EGFR P00533 4/20 0.50
CDK2 P24941 2/20 0.50
JAK2 O60674 1/20 0.50
PIK3CA P42336 1/20 0.50
PIK3CB P42338 1/20 0.50
PIK3CG P48736 1/20 0.50
PTK2B Q14289 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6970735 0.91 EGFR (0.56) ZAP70PRKCAPRKCDPRKD3PRKCG
SCHEMBL5618778 0.83 ZAP70 (0.62) ZAP70PRKCAPRKCDPRKD3PRKCG
SCHEMBL6982104 0.83 IGF1R (0.60) EGFRCDK2BRD4IGF1R
SCHEMBL6967588 0.83 ZAP70 (0.65) ZAP70PRKCAPRKCDPRKD3PRKCG
SCHEMBL6971200 0.83 ZAP70 (0.65) ZAP70PRKCAPRKCDPRKD3PRKCG
Hydrochloric Acid SCHEMBL6970887 0.82 ZAP70 (0.61) ZAP70PRKCAPRKCDPRKD3PRKCG
SCHEMBL6977138 0.80 ZAP70 (0.73) ZAP70PRKCAPRKCDPRKD3PRKCG
SCHEMBL6957546 0.79 ZAP70 (0.71) ZAP70PRKCAPRKCDPRKD3PRKCG
SCHEMBL6974310 0.76 ZAP70 (0.80) ZAP70PRKCAPRKCDPRKD3PRKCG
SCHEMBL6981639 0.74 EGFR (0.71) ZAP70PRKCAPRKCDPRKD3PRKCG

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0862560-B1 SUBSTITUTED 2-ANILINOPYRIMIDINES USEFUL AS PROTEIN KINASE INHIBITORS CELLTECH THERAPEUTICS LTD (GB) 2003-04-02 EP disclosed
US-6235746-B1 AUTOIMMUNE DISEASES; ANTIPROLIFERATIVE AGENT CELLTECH THERAPEUTICS, LIMITED (GB) 2001-05-22 US disclosed
US-5958935-A Substituted 2-anilinopyrimidines useful as protein kinase inhibitors CELLTECH THERAPEUTICS LIMITED (GB) 1999-09-28 US disclosed